loading
前日終値:
$1.14
開ける:
$1.14
24時間の取引高:
31,484
Relative Volume:
0.57
時価総額:
$45.86M
収益:
$13.42M
当期純損益:
$-73.35M
株価収益率:
-0.5469
EPS:
-1.92
ネットキャッシュフロー:
$-56.34M
1週間 パフォーマンス:
-11.02%
1か月 パフォーマンス:
+11.70%
6か月 パフォーマンス:
-26.83%
1年 パフォーマンス:
-70.83%
1日の値動き範囲:
Value
$1.03
$1.14
1週間の範囲:
Value
$1.03
$1.2792
52週間の値動き範囲:
Value
$0.8008
$4.1591

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile

Name
名前
Barinthus Biotherapeutics Plc Adr
Name
セクター
Healthcare (1233)
Name
電話
44 (0) 1865 818808
Name
住所
UNIT 6-10, ZEUS BUILDING, DIDCOT
Name
職員
130
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
BRNS's Discussions on Twitter

BRNS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BRNS
Barinthus Biotherapeutics Plc Adr
1.05 45.86M 13.42M -73.35M -56.34M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.29 106.10B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.54 77.86B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
656.65 39.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.72 30.44B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.51 29.15B 3.30B -501.07M 1.03B -2.1146

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-05-25 開始されました Jefferies Buy
2021-05-25 開始されました Morgan Stanley Overweight
2021-05-25 開始されました William Blair Outperform
2021-05-24 開始されました H.C. Wainwright Buy

Barinthus Biotherapeutics Plc Adr (BRNS) 最新ニュース

pulisher
08:56 AM

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

08:56 AM
pulisher
Nov 15, 2024

New trial shows promise for chronic hepatitis B treatment - Investing.com India

Nov 15, 2024
pulisher
Oct 01, 2024

Barinthus Bio completes enrollment for two clinical trials - Investing.com India

Oct 01, 2024
pulisher
Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024
pulisher
Sep 24, 2024

Barinthus Bio launches Phase 1 celiac disease therapy trial - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Barinthus Biotherapeutics Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Investing.com

Sep 24, 2024
pulisher
Sep 05, 2024

Barinthus Biotherapeutics appoints new COO - Investing.com

Sep 05, 2024
pulisher
Sep 05, 2024

BRNS Stock Touches 52-Week Low at $1.14 Amid Market Challenges - Investing.com UK

Sep 05, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024
pulisher
May 01, 2024

Kintara Therapeutics restructures share designations By Investing.com - Investing.com

May 01, 2024
pulisher
Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024
pulisher
Mar 13, 2024

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Mar 13, 2024
pulisher
Apr 30, 2021

Vaccitech (VACC) Stock Price, News & Analysis - MarketBeat

Apr 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011

Barinthus Biotherapeutics Plc Adr (BRNS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.08
price down icon 0.56%
$71.48
price down icon 1.15%
$362.89
price down icon 1.19%
$42.55
price down icon 1.54%
biotechnology ONC
$177.47
price down icon 0.31%
$123.94
price up icon 1.31%
大文字化:     |  ボリューム (24 時間):